Rick Ryan is an Operating Partner at Cultivation Capital with over 40 years in life sciences. He co-founded Apertus Pharmaceuticals and previously held leadership roles at Monsanto, Embrex, Linco Research, and Millipore.
What Rick can write
Cultivation Capital writes $100K to $10M checks, larger than 5% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: Cultivation Capital.Career
- Monsanto Corporation · several leadership roles
- Embrex Inc · vaccine commercial development
- Linco Research · President
- Millipore Corporation · Vice President of the Drug Discovery and Development business unit
- Cultivation Capital · Operating PartnerNow
- Monsanto Corporation
- Embrex Inc
- Apertus Pharmaceuticals · Chairman of the Board
Companies founded
Investments named in public bios
Focus
Education
Also at Cultivation Capital
Partners like Rick
At firms with a similar stage, sector and check size.
Alert me when Cultivation Capital is active
One email when Rick's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Rick Ryan?
Rick Ryan is an Operating Partner at Cultivation Capital with over 40 years in life sciences. He co-founded Apertus Pharmaceuticals and previously held leadership roles at Monsanto, Embrex, Linco Research, and Millipore.
How much does Rick Ryan invest?
Rick Ryan invests through Cultivation Capital, which writes checks of $100K to $10M at seed, series a, series b.
How do I pitch Rick Ryan?
Email [email protected], the firm's inbox for founders, and name Rick in the subject. A warm intro from a founder Cultivation Capital backed works better.
What did Rick Ryan do before Cultivation Capital?
several leadership roles at Monsanto Corporation; vaccine commercial development at Embrex Inc; President at Linco Research; Vice President of the Drug Discovery and Development business unit at Millipore Corporation; Monsanto Corporation; Embrex Inc; Chairman of the Board at Apertus Pharmaceuticals.
Last updated 2026-10-15. Is this you? Ask for a correction.